4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FDMT 4D Molecular Therapeutics

休市中 12-20 15:59:59 EST

6.31

+0.53

+9.17%

盘后6.31

+0.000.00%

19:40 EST

最高6.37	最低5.74	成交量476.51万
今开5.74	昨收5.78	日振幅10.90%
总市值2.92亿	流通市值1.94亿	总股本4,623万
成交额2,971万	换手率15.46%	流通股本3,082万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FDMT","market":"US","secType":"STK","nameCN":"4D Molecular Therapeutics","latestPrice":6.31,"timestamp":1734728399999,"preClose":5.78,"halted":0,"volume":4765130,"hourTrading":{"tag":"盘后","latestPrice":6.31,"preClose":6.31,"latestTime":"19:40 EST","volume":152702,"amount":963799.54,"timestamp":1734741653611},"delay":0,"floatShares":30816731,"shares":46227700,"eps":-2.827187,"marketStatus":"休市中","marketStatusCode":7,"change":0.53,"latestTime":"12-20 15:59:59 EST","open":5.74,"high":6.37,"low":5.74,"amount":29705669.365379,"amplitude":0.108997,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.827187,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1607662800000,"adjPreClose":5.78,"postHourTrading":{"tag":"盘后","latestPrice":6.31,"preClose":6.31,"latestTime":"19:40 EST","volume":152702,"amount":963799.54,"timestamp":1734741653611},"volumeRatio":3.967006395826131,"impliedVol":0.8226,"impliedVolPercentile":0.4802},"requestUrl":"/m/hq/s/FDMT","defaultTab":"news","newsList":[{"id":"2492405664","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘大幅上涨5.28%报6.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492405664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492405664?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:39","pubTimestamp":1734705561,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时39分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速上涨5.28%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte, Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为1838.03%、83.66%、55.33%，振幅较大的相关个股有Humacyte, Inc.、Humacyte Inc C/Wts 27/08/2026 、Quoin Pharmaceuticals Ltd，振幅分别为35.26%、34.80%、30.92%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223921a1fe2831&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223921a1fe2831&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FDMT","LENZ"],"gpt_icon":0},{"id":"2492180243","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492180243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492180243?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:18","pubTimestamp":1734535112,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日23时18分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速跳水5.06%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为2128.83%、431.92%、283.82%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为227.62%、97.69%、66.83%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218231832ab821cb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218231832ab821cb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FDMT","LENZ"],"gpt_icon":0},{"id":"2489241885","title":"4D Molecular Therapeutics, Inc.盘中异动 临近收盘急速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489241885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489241885?lang=zh_cn&edition=full","pubTime":"2024-12-06 04:38","pubTimestamp":1733431138,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日04时38分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅下跌5.04%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Protara Therapeutics, Inc.、Camp4 Therapeutics Corporation、Cardio Diagnostics Holdings Inc.涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Protara Therapeutics, Inc.较为活跃，换手率分别为3711.89%、2365.45%、528.19%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Protara Therapeutics, Inc.、Molecular Templates, Inc.，振幅分别为136.00%、127.97%、124.83%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206043859a1d73e85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206043859a1d73e85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FDMT","LENZ"],"gpt_icon":0},{"id":"2488925992","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488925992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488925992?lang=zh_cn&edition=full","pubTime":"2024-12-04 01:05","pubTimestamp":1733245536,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日01时05分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速跳水5.14%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Janux Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为145.45%、135.96%、120.66%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为69.23%、59.76%、51.13%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120401053698e52274&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120401053698e52274&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FDMT"],"gpt_icon":0},{"id":"2486932809","title":"4D Molecular Therapeutics, Inc.盘中异动 下午盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486932809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486932809?lang=zh_cn&edition=full","pubTime":"2024-11-28 03:34","pubTimestamp":1732736064,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日03时34分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速拉升5.07%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112803342498e44ffa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112803342498e44ffa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FDMT"],"gpt_icon":0},{"id":"2486077080","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486077080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486077080?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545229,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速拉升5.52%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为87.24%、61.67%、38.71%，振幅较大的相关个股有Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.、Kodiak Sciences Inc，振幅分别为105.47%、105.26%、105.01%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522334998e4465e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522334998e4465e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4139"],"gpt_icon":0},{"id":"2485219823","title":"4D Molecular Therapeutics, Inc.盘中异动 下午盘股价大跌5.01%报7.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485219823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485219823?lang=zh_cn&edition=full","pubTime":"2024-11-23 03:52","pubTimestamp":1732305161,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日03时52分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速跳水5.01%。截至发稿，该股报7.59美元/股，成交量41.5305万股，换手率0.90%，振幅6.38%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123035241a24e9fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123035241a24e9fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FDMT"],"gpt_icon":0},{"id":"2485298179","title":"4D Molecular Therapeutics, Inc.2024财年第三财季实现净利润-43.84百万美元，同比减少327.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298179?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:01","pubTimestamp":1732291273,"startTime":"0","endTime":"0","summary":"11月23日，4D Molecular Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-43.84百万美元，同比减少327.29%；其中营业收入为3000.00美元，同比减少99.99%，每股基本收益为-0.79美元。从资产负债表来看，4D Molecular Therapeutics, Inc.总负债51.08百万美元，其中短期债务5.09百万美元，资产负债比为0.12，流动比率为0.18。机构评级：截至2024年11月23日，当前有10家机构对4D Molecular Therapeutics, Inc.目标价做出预测，其中目标均价为45.70美元，其中最低目标价为8.00美元，最高目标价为82.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000138a24e48ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000138a24e48ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT"],"gpt_icon":0},{"id":"2485407127","title":"4D Molecular Therapeutics, Inc.盘中异动 下午盘大幅跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485407127","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485407127?lang=zh_cn&edition=full","pubTime":"2024-11-21 04:21","pubTimestamp":1732134069,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日04时21分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速下挫5.07%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Exicure, Inc.涨幅较大，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃，换手率分别为1934.92%、1344.46%、1025.30%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.，振幅分别为185.64%、169.09%、136.94%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121042109971a7c10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121042109971a7c10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FDMT"],"gpt_icon":0},{"id":"2484660166","title":"4D Molecular Therapeutics, Inc.盘中异动 急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484660166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484660166?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:46","pubTimestamp":1731951997,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时46分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速下跌5.06%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Hcw Biologics Inc.、冠科美博、Tharimmune, Inc.较为活跃，换手率分别为1113.31%、737.25%、566.02%，振幅较大的相关个股有Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博，振幅分别为563.48%、129.51%、95.10%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111901463798e4351e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111901463798e4351e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","BK4139","LENZ"],"gpt_icon":0},{"id":"2483558804","title":"4D Molecular Therapeutics, Inc.盘中异动 快速下跌5.06%报7.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483558804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483558804?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:39","pubTimestamp":1731595199,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时39分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速跳水5.06%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1705.95%、24.28%、17.04%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Taysha Gene Therapies, Inc.，振幅分别为75.00%、38.46%、26.24%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224000a237d6db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224000a237d6db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FDMT"],"gpt_icon":0},{"id":"2483050876","title":"美国研究综述-思科、Freshpet、Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2483050876","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483050876?lang=zh_cn&edition=full","pubTime":"2024-11-14 20:06","pubTimestamp":1731585982,"startTime":"0","endTime":"0","summary":"美国研究综述-思科、Freshpet、Nvidia路透11月14日 - 华尔街证券分析师周四调整了对思科、Freshpet 和 Nvidia 等几家美国上市公司的评级和目标价。要闻 * 思科CSCO.O：杰富瑞将目标价从53美元上调至66美元 * Freshpet Inc FRPT.O：奥本海默将目标价从155美元上调至180美元  * ICU Medical Inc ICUI.O：Raymond James将目标价从190美元上调至205美元  * Kronos Bio Inc KRON.O：TD Cowen将目标价从买入下调至持有 * Nvidia Corp NVDA.O：奥本海默将目标价从 150 美元上调至 175 美元 以下是路透周四报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML18A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","AXTA","LU1244550577.SGD","CNNE","BK4209","ALSN","AVB","BK4550","BPMC","LU1244550494.USD","CSCO","LU0300736492.USD","LU1894683348.USD","ALLO","SG9999002232.USD","CHGG","IE00BZ1G4Q59.USD","CAKE","ALMS","CHX","APEI","CPAY","CPT","BRBR","DOX","FDMT","CPB","AZTA","IE00BFXG1179.USD","CRVS","CBSH","LU0868494708.USD","AROC","CAVA","COGT","BWXT","BTMD","AIT","LU2106854487.HKD","BIIB","SPRY","ACRV","ADAP","APD","SLRN","BKR","AESI","LU0234572021.USD","CTRA","EE"],"gpt_icon":0},{"id":"2478848784","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478848784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478848784?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:12","pubTimestamp":1730124762,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时12分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速拉升5.03%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Monte Rosa Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Tc Biopharm  Plc、Genprex, Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为619.58%、52.15%、51.74%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.，振幅分别为87.13%、84.14%、46.83%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028221242971a2ab3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028221242971a2ab3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FDMT","LENZ"],"gpt_icon":0},{"id":"2473488549","title":"4D Molecular Therapeutics, Inc.盘中异动 临近午盘急速下跌5.01%报9.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473488549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473488549?lang=zh_cn&edition=full","pubTime":"2024-10-07 23:54","pubTimestamp":1728316444,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日23时54分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速下跌5.01%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Scholar Rock Holding Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Aditxt, Inc.、Tc Biopharm  Plc、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1294.48%、57.64%、55.11%，振幅较大的相关个股有Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为99.06%、39.46%、36.71%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007235405ab681eed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007235405ab681eed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FDMT","LENZ"],"gpt_icon":0},{"id":"2473699347","title":"4D Molecular Therapeutics, Inc.盘中异动 急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473699347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473699347?lang=zh_cn&edition=full","pubTime":"2024-10-05 02:13","pubTimestamp":1728065618,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日02时13分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅下挫5.03%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Theriva Biologics, Inc.、Seelos Therapeutics, Inc.较为活跃，换手率分别为17335.36%、74.74%、67.12%，振幅较大的相关个股有Aditxt, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为69.59%、58.64%、56.26%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100502133998e3aa62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100502133998e3aa62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FDMT","LENZ"],"gpt_icon":0},{"id":"2468462034","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468462034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468462034?lang=zh_cn&edition=full","pubTime":"2024-09-20 23:13","pubTimestamp":1726845199,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日23时13分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅跳水5.04%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.59%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202313199719c097&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202313199719c097&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FDMT","LENZ"],"gpt_icon":0},{"id":"2468357743","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘急速下跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468357743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468357743?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:34","pubTimestamp":1726752870,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时34分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速下挫5.59%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为1068.11%、380.50%、73.59%，振幅较大的相关个股有Exicure, Inc.、Portage Biotech Inc.、Transcode Therapeutics, Inc.，振幅分别为54.59%、18.67%、15.60%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091921343098e38169&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091921343098e38169&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FDMT"],"gpt_icon":0},{"id":"2468054956","title":"美国研究综述-阿蒂拉制药公司、劳氏公司、宝洁公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2468054956","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468054956?lang=zh_cn&edition=full","pubTime":"2024-09-19 15:26","pubTimestamp":1726730808,"startTime":"0","endTime":"0","summary":"    路透9月19日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Athira 制药公司、劳氏公司和宝洁公司。要闻              * Athira pharma Inc   ：瑞穗将其评级从 \"跑赢大盘 \"下调至 \"中性\"。* Lowe's Companies Inc   ：TD Cowen将目标价从240美元上调至265美元             * 宝洁  ：摩根大通将目标价从179美元上调至186美元             * SS&C Technologies Holdings Inc   ：加拿大皇家银行将目标价从75美元上调至86美元 以下是路透周四报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RYAM","IE00B2PGVK34.USD","LU1621767810.EUR","BK4154","HQY","LU0266013472.USD","BK4566","FDMT","GTY","LU0109394709.USD","KMX","LU0320765489.SGD","ABT","LU0477156953.USD","LOW","FTAI","IE00BMG7P819.SGD","DRVN","NEP","LU2237957811.SGD","IE00BD4GTT62.SGD","LU2106854487.HKD","LU0096364046.USD","BK4590","SGXZ23171101.USD","ATHA","LU0130518102.USD","LU2242652126.USD","GIS","LU0320765992.SGD","BK4512","BK4527","SSNC","BK4100","PG","LU1621767737.EUR","LU0889566641.SGD","BK4532","SG9999014575.USD","LU1989763427.SGD","PGNY","LU1974910355.USD","CHTR","LU0124676726.USD","NEE","HALO","FIVE"],"gpt_icon":1},{"id":"2462992881","title":"4D Molecular Therapeutics, Inc.盘中异动 急速拉升5.28%报15.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462992881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462992881?lang=zh_cn&edition=full","pubTime":"2024-08-27 03:10","pubTimestamp":1724699428,"startTime":"0","endTime":"0","summary":"北京时间2024年08月27日03时10分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速拉升5.28%。截至发稿，该股报15.75美元/股，成交量19.2729万股，换手率0.37%，振幅4.41%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408270310289719a0d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408270310289719a0d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FDMT","LENZ"],"gpt_icon":0},{"id":"2460241118","title":"4D Molecular Therapeutics, Inc.2024财年第二财季实现净利润-34.95百万美元，同比减少17.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460241118","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460241118?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824038,"startTime":"0","endTime":"0","summary":"8月17日，4D Molecular Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-34.95百万美元，同比减少17.99%；其中营业收入为5000.00美元，同比减少97.91%，每股基本收益为-0.63美元。从资产负债表来看，4D Molecular Therapeutics, Inc.总负债31.78百万美元，其中短期债务3.20百万美元，资产负债比为0.20，流动比率为0.29。机构评级：截至2024年8月17日，当前有10家机构对4D Molecular Therapeutics, Inc.目标价做出预测，其中目标均价为50.30美元，其中最低目标价为36.00美元，最高目标价为82.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006159f31b167&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006159f31b167&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.4dmoleculartherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0292},{"period":"1month","weight":-0.2497},{"period":"3month","weight":-0.4697},{"period":"6month","weight":-0.7249},{"period":"1year","weight":-0.6914},{"period":"ytd","weight":-0.6885}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"4D Molecular Therapeutics, Inc.于2015年3月11日根据特拉华州法律成立。该公司是一家临床阶段基因治疗公司，开创了利用其靶向和进化的AAV载体开发候选产品的先河。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.114674},{"month":2,"riseRate":0.25,"avgChangeRate":0.09912},{"month":3,"riseRate":0.75,"avgChangeRate":0.041874},{"month":4,"riseRate":0.25,"avgChangeRate":-0.130346},{"month":5,"riseRate":0.5,"avgChangeRate":-0.163827},{"month":6,"riseRate":0,"avgChangeRate":-0.078465},{"month":7,"riseRate":0.75,"avgChangeRate":0.059232},{"month":8,"riseRate":0.25,"avgChangeRate":-0.049809},{"month":9,"riseRate":0.25,"avgChangeRate":-0.148039},{"month":10,"riseRate":0.25,"avgChangeRate":-0.11181},{"month":11,"riseRate":0.5,"avgChangeRate":0.477816},{"month":12,"riseRate":0.25,"avgChangeRate":0.067609}],"exchange":"NASDAQ","name":"4D Molecular Therapeutics","nameEN":"4D Molecular Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"4D Molecular Therapeutics,FDMT,4D Molecular Therapeutics股票,4D Molecular Therapeutics股票老虎,4D Molecular Therapeutics股票老虎国际,4D Molecular Therapeutics行情,4D Molecular Therapeutics股票行情,4D Molecular Therapeutics股价,4D Molecular Therapeutics股市,4D Molecular Therapeutics股票价格,4D Molecular Therapeutics股票交易,4D Molecular Therapeutics股票购买,4D Molecular Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}